Contrast

Contact

Share

Donate

MyChart

Help

Yale New Haven Health names Beth Beckman chief nursing executive

Thursday, September 6, 2018

beth beckman

New Haven, CT (Sept. 11, 2018) – Yale New Haven Health (YNHHS) has named  Beth P. Beckman, DNSc to serve as the inaugural chief nursing executive for health system. In this new role, Beckman will be responsible for developing and overseeing the system-wide integration plan for key components of nursing, including nursing practice, staffing, education/development and communication. Under her leadership, YNHHS will establish a signature standard of nursing care focused on patient-centered clinical excellence.

“Yale New Haven Health is very excited to add Beth Beckman as our chief nursing executive,”  said Richard D’Aquila, president, Yale New Haven Health and Yale New Haven Hospital. “As a destination health system, her outstanding track record, list of accomplishments and commitment to nursing excellence and patient care will enhance nursing and the patient experience across all of our delivery networks.” 

Beckman comes to YNHHS after serving as the vice president and chief nursing officer (CNO) of Baylor University Medical Center (BUMC) in Dallas, Texas. Beth joined the BUMC leadership team as CNO in 2016. She had previously served at Baylor Scott & White Medical Center – Grapevine since 2008, including in a dual role as CNO and chief operating officer. Under her skillful leadership, both BUMC and Grapevine achieved major milestones in patient safety, clinical outcomes, patient experience and nursing practice. Beckman led the extensive efforts that resulted in BUMC being re-designated as a Magnet Hospital for the fourth time in May 2018. In her role at Baylor, she was instrumental in working with multidisciplinary teams to drive clinical transformation and coordination, leading to improved patient care outcomes and hospital operations. 

Beckman obtained her Doctor of Nursing Science degree from Johns Hopkins University School of Nursing, Master of Science in Nursing – Family Nurse Practitioner track from Arizona State University and Bachelor of Science in Nursing from University of Arizona. 

Beckman will work closely with local delivery network presidents, CNOs, Nursing vice presidents and chief medical officers to successfully realize the integrated System nursing vision. She will also be concurrently appointed as the associate dean for partnerships for the Yale School of Nursing. 

Beckman will be relocating to New Haven with her husband and has grown children in Arizona and Dallas-Fort Worth.  

Yale New Haven Health (YNHHS), the largest and most comprehensive healthcare system in Connecticut, is recognized for advanced clinical care, quality, service, cost effectiveness and commitment to improving the health status of the communities it serves. YNHHS includes five hospitals – Bridgeport, Greenwich, Lawrence + Memorial, Westerly and Yale New Haven hospitals, several specialty networks and Northeast Medical Group, a non-profit medical foundation with several hundred community-based and hospital-employed physicians. YNHHS is affiliated with Yale University and Yale Medicine, the clinical practice of the Yale School of Medicine and the largest academic multi-specialty practice in New England. Yale New Haven Hospital is the primary teaching hospital of Yale School of Medicine. www.ynhhs.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.